Skip to content

Author

Feng-Yi Guo

We have 2 of 5 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Aug 2026

Erchen Decoction Alleviates MAFLD by Regulating MFN2-mediated Endoplasmic Reticulum Stress.

EC exerts significant protective effects against MAFLD by upregulating the MFN2/ERMIT2 axis and suppressing the PERK, eIF2α, and ATF4 ERS pathway, suggesting a restorative effect on calcium handling, maintains ER homeostasis, and reduces hepatocyte injury, highlighting EC as a promising therapeutic candidate for MAFLD.

Qing-Xuan He, Meng-Zhen Wang, Xu Wang et al. · 0 citations
Aug 2026

Identification of Lactate-related Biomarkers in Non-alcoholic Fatty Liver Disease.

These findings bridge the gap between metabolic lipotoxicity and epigenetic regulation, suggesting that lactylation acts as a critical driver in NAFLD pathogenesis.

Qing-Xuan He, Xu Wang, Peng-Fei Wang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.